Please login to the form below

Not currently logged in
Email:
Password:

US market

This page shows the latest US market news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca buys FDA priority review voucher from Sobi

AstraZeneca buys FDA priority review voucher from Sobi

A PRV reduces the target review time of the drug application from ten to six months, and the value of gaining an earlier launch on the US market could be worth ... AZ has not yet said how it will use the PRV, but the company could gain competitive

Latest news

  • Cello Health acquires US consultancy ISS Cello Health acquires US consultancy ISS

    Follows recent expansion into Germany. Cello Health has announced further expansion into the US market with the acquisition of New Jersey-based company Innovative Science Solutions, LLC (ISS) on 15 August. ... Its clients are predominantly US based,

  • AbbVie scores FDA approval for arthritis treatment upadacitinib AbbVie scores FDA approval for arthritis treatment upadacitinib

    Biosimilar competition is already harming Humira in Europe and AbbVie needs its new products to offset the expected competition in the US market from 2023 when its patent expires. ... The JAK inhibitor market competition has also become increasingly

  • Leo Pharma to market AstraZeneca’s brodalumab outside Europe Leo Pharma to market AstraZeneca’s brodalumab outside Europe

    Extends reach of the drug. Leo Pharma has acquired the rights to develop and market psoriasis treatment brodalumab outside Europe. . ... However, Bausch Health still retains the rights to develop and market brodalumab within the US and Canada.

  • GSK hires Merck KGaA exec to lead US pharma business GSK hires Merck KGaA exec to lead US pharma business

    Martinez-Davis will play a role in trying to make a success of those launches, leveraging both her experience of oncology drugs and the US market. ... to expanding our specialty care capabilities and market presence,” said Luke Miels, president of

  • Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose' Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'

    market, thereby eliminating a competitor that could have brought the price of the drug down. ... Acthar came to market in the US in 1952 with a broad label reflecting the approval practices of the time and evidence that the drug triggers

More from news
Approximately 1 fully matching, plus 787 partially matching documents found.

Latest Intelligence

  • It’s not the end of the world, is it? It’s not the end of the world, is it?

    the US market when they would, de facto, be barred from other developed and price-controlled markets. ... It would have a disproportionate effect, for example, on companies who depend heavily on the US market.

  • Vertex: a vision of treating all CF patients worldwide draws closer Vertex: a vision of treating all CF patients worldwide draws closer

    The chosen candidate is then expected to gain approval in the US market in the first half of 2020, followed by Europe in the first half of 2021. ... Y. Katherine Xu, an analyst at William Blair, forecast peak annual sales of $10.2bn, up from $8.9bn

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Almost all sales come from the US market, mainly because of supply constraints for Cinryze in recent years, something that the combined company will aim to address. ... In the long term, a US market share of 10% of the number of patients treated, or

  • Is China ready for a pharmaceutical gold rush?

    Rapidly growing sector. The US alone holds over 45% of the global pharmaceutical market. ... Indeed, BMS will pitch Opdivo at half the US list price, determining the true value of market access.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

More from intelligence
Approximately 0 fully matching, plus 48 partially matching documents found.

Latest appointments

  • New faces at 11 London, ramarketing and MSL New faces at 11 London, ramarketing and MSL

    The new office in Cambridge, Massachusetts, will give ramarketing a presence in the growing pharma and biotech hub and a foothold in the US market, allowing it to locally service its ... Emma’s insight into the global life sciences sector means she

  • Pharma industry appointments Pharma industry appointments

    Prior to this, Jenkins spent 17 years at GlaxoSmithKline (GSK) in the UK and US. ... UK. Vu, whose new post will see him further expand Concept’s presence in the US market, joins the company with over 15 years’ experience in both business development

  • Open Health creates new role Open Health creates new role

    Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services. ... Creating a unique role within our field of expertise will enable us to offer a

  • W2O bolsters its commercialisation offering W2O bolsters its commercialisation offering

    Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications offering.

  • Amra appoints new VP of North American sales Jeremy Edwards Amra appoints new VP of North American sales Jeremy Edwards

    With more than 20 years’ experience in the clinical development industry, Edwards joins the company after spending five years as vice president and general manager of the US operations for Exco ... expand the US market.”.

More from appointments
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 34 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics